ABSTRACT
Cost-effectiveness analysis (CEA) is an important tool in health care decision-making. Here, we consider methodological issues associated with CEA, and review alternative approaches that are in use by practitioners and recent developments in the field. Special reference is made to the incorporation of evidence through indirect comparisons, as well as data from noninterventional studies. The use of decision trees and Markov models is highlighted, and illustrative examples are given.
